Publication | Closed Access

MEDI0382, a GLP-1 and glucagon receptor dual agonist, in obese or overweight patients with type 2 diabetes: a randomised, controlled, double-blind, ascending dose and phase 2a study

ObesityMetabolic SyndromeMedicineDiabetesType 2Obesity ManagementPhase 2ADiabetes MellitusPharmacologyOverweight Patients